Skip to content. | Skip to navigation

IMPaCT Trial

Individualised Molecular Pancreatic Cancer Therapy (IMPaCT) is a new clinical trial looking at individualising the treatment of patients with metastatic pancreatic cancer.

Make a Donation

Help the APGI and ensure our work continues. Make a donation today.

Get Email Updates
Familial Cancer Cohort

If you would like to be involved in the project please click here to find out more.


Governance & Leadership

Leadership Teams

The APGI project is a collaborative, team-science effort. Central operation, strategy and development of APGI research and services are governed by particular teams. Given the expansive and global nature of the APGI, a Leadership Advisory Team has been appointed to direct and develop. The Leadership Advisory Team also assists in development and management of overall strategy, but is primarily responsible for operation of the APGI and the approval of access to material and data held by the APGI.

Read More…


Although housed at the Garvan Institute of Medical Research in Sydney, the APGI central project is a collaborative, team-science effort. Our collaborators have included pancreatic cancer healthcare professionals and experts in major hospitals and research facilities across Australia. We also have international links with major pancreatic healthcare research centres in the USA, Canada and Italy. This project would not have been possible without the dedication and support of each and everyone of you. From the APGI team, a very big thank you to all!

Read More…

Strategic Partner Institutions, Groups & Organisations

The APGI is supported in various ways by a number of strategic partners. Our partners range from academic institutions, scientific specialty groups, philanthropic organisations, clinical bodies, translational research centres and professional organisations.

Read More…